Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Hoffmann

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
The Lancet. Infectious Diseases|December 5, 2016
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort studyJohn Gregson, Pontiano Kaleebu, Vincent C Marconi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 1, 2020
Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional studyGeorge A Yendewa, Sulaiman Lakoh, Sahr A Yendewa, et al.
Plos One|August 25, 2025
Bon bagay (good stuff): A faith-based outlook on biomedical prevention among Haitians and Haitian AmericansCandice A Sternberg, Maurice J Chery, Maika Beauvoir, et al.
BMJ Global Health|May 24, 2025
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trialKate Shearer, Bareng A S Nonyane, Christiaan Mulder, et al.
Journal of the International Association of Providers of AIDS Care|June 5, 2026
Clinic and Provider Innovations to Improve Tuberculosis Infection Screening and Preventive Therapy Uptake in Brazil: Qualitative Findings From the PREVINE-TB StudyDeanna Kerrigan, Lelia H Chaisson, Paula Travassos, et al.
Science Translational Medicine|August 13, 2025
Proviruses in CD4<sup>+</sup> T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremiaFengting Wu, Milica Moskovljevic, Filippo Dragoni, et al.
PLOS Global Public Health|March 24, 2023
Contextualizing and optimizing novel strategies to improve the latent TB continuum of care: Insights from people living with HIV and health care providers in BrazilIsadora Salles, Paula Travassos, Renata Spener-Gomes, et al.
The Journal of Clinical Investigation|January 5, 2023
Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremiaJennifer A White, Fengting Wu, Saif Yasin, et al.
Nature Communications|June 8, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ARTJulia R Box, Angelica Camilo-Contreras, Filippo Dragoni, et al.
Ebiomedicine|April 3, 2017
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International CollaborationSoo-Yon Rhee, Vici Varghese, Susan P Holmes, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
The Lancet. Infectious Diseases|December 5, 2016
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort studyJohn Gregson, Pontiano Kaleebu, Vincent C Marconi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 1, 2020
Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional studyGeorge A Yendewa, Sulaiman Lakoh, Sahr A Yendewa, et al.
Plos One|August 25, 2025
Bon bagay (good stuff): A faith-based outlook on biomedical prevention among Haitians and Haitian AmericansCandice A Sternberg, Maurice J Chery, Maika Beauvoir, et al.
BMJ Global Health|May 24, 2025
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trialKate Shearer, Bareng A S Nonyane, Christiaan Mulder, et al.
Journal of the International Association of Providers of AIDS Care|June 5, 2026
Clinic and Provider Innovations to Improve Tuberculosis Infection Screening and Preventive Therapy Uptake in Brazil: Qualitative Findings From the PREVINE-TB StudyDeanna Kerrigan, Lelia H Chaisson, Paula Travassos, et al.
Science Translational Medicine|August 13, 2025
Proviruses in CD4<sup>+</sup> T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremiaFengting Wu, Milica Moskovljevic, Filippo Dragoni, et al.
PLOS Global Public Health|March 24, 2023
Contextualizing and optimizing novel strategies to improve the latent TB continuum of care: Insights from people living with HIV and health care providers in BrazilIsadora Salles, Paula Travassos, Renata Spener-Gomes, et al.
The Journal of Clinical Investigation|January 5, 2023
Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremiaJennifer A White, Fengting Wu, Saif Yasin, et al.
Nature Communications|June 8, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ARTJulia R Box, Angelica Camilo-Contreras, Filippo Dragoni, et al.
Ebiomedicine|April 3, 2017
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International CollaborationSoo-Yon Rhee, Vici Varghese, Susan P Holmes, et al.
Pageof 14